Editorial
Inhibidores selectivos de fosfodiesterasas, una nueva opción terapéutica en inflamación y autoinmunidad
Selective Phosphodiesterase Inhibitors: A New Therapeutic Option in Inflammation and Autoimmunity
Read
46762
Timeswas read the article
6359
Total PDF
40403
Total HTML
Share statistics
Article information
ISSN: 1699258XOriginal language: Spanish
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2026 1 | 470 | 127 | 597 |
| 2025 12 | 497 | 211 | 708 |
| 2025 11 | 441 | 70 | 511 |
| 2025 10 | 27 | 82 | 109 |
| 2025 9 | 0 | 76 | 76 |
| 2025 8 | 0 | 95 | 95 |
| 2025 7 | 0 | 58 | 58 |
| 2025 6 | 14 | 51 | 65 |
| 2025 5 | 537 | 96 | 633 |
| 2025 4 | 433 | 63 | 496 |
| 2025 3 | 709 | 63 | 772 |
| 2025 2 | 580 | 62 | 642 |
| 2025 1 | 572 | 69 | 641 |
| 2024 12 | 510 | 49 | 559 |
| 2024 11 | 489 | 77 | 566 |
| 2024 10 | 402 | 43 | 445 |
| 2024 9 | 434 | 48 | 482 |
| 2024 8 | 404 | 70 | 474 |
| 2024 7 | 423 | 36 | 459 |
| 2024 6 | 393 | 63 | 456 |
| 2024 5 | 393 | 72 | 465 |
| 2024 4 | 420 | 55 | 475 |
| 2024 3 | 399 | 59 | 458 |
| 2024 2 | 423 | 52 | 475 |
| 2024 1 | 579 | 55 | 634 |
| 2023 12 | 476 | 55 | 531 |
| 2023 11 | 643 | 45 | 688 |
| 2023 10 | 697 | 53 | 750 |
| 2023 9 | 591 | 49 | 640 |
| 2023 8 | 436 | 40 | 476 |
| 2023 7 | 414 | 70 | 484 |
| 2023 6 | 506 | 60 | 566 |
| 2023 5 | 630 | 51 | 681 |
| 2023 4 | 497 | 71 | 568 |
| 2023 3 | 659 | 57 | 716 |
| 2023 2 | 477 | 64 | 541 |
| 2023 1 | 372 | 39 | 411 |
| 2022 12 | 361 | 62 | 423 |
| 2022 11 | 486 | 96 | 582 |
| 2022 10 | 476 | 82 | 558 |
| 2022 9 | 357 | 52 | 409 |
| 2022 8 | 343 | 63 | 406 |
| 2022 7 | 318 | 73 | 391 |
| 2022 6 | 291 | 62 | 353 |
| 2022 5 | 423 | 86 | 509 |
| 2022 4 | 329 | 119 | 448 |
| 2022 3 | 296 | 67 | 363 |
| 2022 2 | 320 | 61 | 381 |
| 2022 1 | 335 | 69 | 404 |
| 2021 12 | 349 | 71 | 420 |
| 2021 11 | 464 | 72 | 536 |
| 2021 10 | 355 | 86 | 441 |
| 2021 9 | 371 | 85 | 456 |
| 2021 8 | 337 | 100 | 437 |
| 2021 7 | 328 | 65 | 393 |
| 2021 6 | 476 | 102 | 578 |
| 2021 5 | 523 | 110 | 633 |
| 2021 4 | 1095 | 160 | 1255 |
| 2021 3 | 657 | 66 | 723 |
| 2021 2 | 382 | 43 | 425 |
| 2021 1 | 360 | 61 | 421 |
| 2020 12 | 397 | 36 | 433 |
| 2020 11 | 625 | 54 | 679 |
| 2020 10 | 552 | 47 | 599 |
| 2020 9 | 442 | 41 | 483 |
| 2020 8 | 408 | 46 | 454 |
| 2020 7 | 386 | 51 | 437 |
| 2020 6 | 465 | 52 | 517 |
| 2020 5 | 471 | 56 | 527 |
| 2020 4 | 517 | 43 | 560 |
| 2020 3 | 452 | 43 | 495 |
| 2020 2 | 419 | 48 | 467 |
| 2020 1 | 392 | 39 | 431 |
| 2019 12 | 310 | 27 | 337 |
| 2019 11 | 333 | 34 | 367 |
| 2019 10 | 353 | 21 | 374 |
| 2019 9 | 359 | 41 | 400 |
| 2019 8 | 244 | 27 | 271 |
| 2019 7 | 236 | 32 | 268 |
| 2019 6 | 300 | 30 | 330 |
| 2019 5 | 379 | 69 | 448 |
| 2019 4 | 360 | 34 | 394 |
| 2019 3 | 209 | 24 | 233 |
| 2019 2 | 166 | 33 | 199 |
| 2019 1 | 154 | 33 | 187 |
| 2018 12 | 334 | 59 | 393 |
| 2018 11 | 384 | 16 | 400 |
| 2018 10 | 359 | 19 | 378 |
| 2018 9 | 320 | 13 | 333 |
| 2018 8 | 409 | 16 | 425 |
| 2018 7 | 71 | 20 | 91 |
| 2018 5 | 31 | 1 | 32 |
| 2018 4 | 251 | 22 | 273 |
| 2018 3 | 199 | 15 | 214 |
| 2018 2 | 146 | 7 | 153 |
| 2018 1 | 79 | 14 | 93 |
| 2017 12 | 121 | 14 | 135 |
| 2017 11 | 178 | 13 | 191 |
| 2017 10 | 137 | 14 | 151 |
| 2017 9 | 143 | 34 | 177 |
| 2017 8 | 132 | 30 | 162 |
| 2017 7 | 127 | 34 | 161 |
| 2017 6 | 153 | 40 | 193 |
| 2017 5 | 182 | 33 | 215 |
| 2017 4 | 120 | 34 | 154 |
| 2017 3 | 152 | 49 | 201 |
| 2017 2 | 204 | 37 | 241 |
| 2017 1 | 344 | 82 | 426 |
| 2016 12 | 365 | 125 | 490 |
| 2016 11 | 466 | 166 | 632 |
| 2016 10 | 40 | 58 | 98 |
| 2016 9 | 25 | 43 | 68 |
| 2016 8 | 23 | 21 | 44 |
Show all
